SD:NYSESandRidge Energy, Inc. Analysis
Data as of 2026-05-26 - not real-time
$15.26
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
SandRidge Energy posted a solid Q1 2026, with revenue climbing ~17% YoY and profit margins above 45%, while the board lifted the quarterly dividend by 8% to $0.13 and added a one‑time $0.20 payout, underscoring cash strength. Operating cash flow rose to $34.4 M and the balance sheet remains tight with debt under $2 M, delivering a low debt‑to‑equity of 0.32. Technically, the stock sits just above its 20‑day SMA (≈15.26) and is bounded by support at $14.37 and resistance near $16.09; RSI at 49 and a bullish MACD histogram suggest a neutral‑to‑slightly‑upward bias. Valuation metrics are compelling: a trailing PE of ~7.4 versus an industry average of ~21.6, a price‑to‑book near parity, and a DCF‑derived fair value far above the current $15.26 price, indicating potential undervaluation. The 3.4% dividend yield, coupled with a modest 23% payout ratio, appears sustainable given the strong cash generation. However, 30‑day volatility is high (~41%) and daily volume is well below its 10‑day average, flagging liquidity concerns. Overall, the company blends attractive income, solid fundamentals, and a discounted valuation, but investors should remain mindful of sector cyclicality and price volatility.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Dividend increase and special payout boost income appeal
- Technical indicators are neutral with support intact
- High short‑term volatility and low trading volume
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Significant valuation gap (PE ~7.4 vs industry ~21.6)
- Sustained earnings growth and strong cash flow
- Attractive dividend yield with low payout ratio
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Energy sector cyclicality introduces macro risk
- Long‑term undervaluation relative to DCF fair value
- Robust balance sheet supports dividend continuity
Key Metrics & Analysis
Financial Health
Revenue Growth16.80%
Profit Margin46.37%
P/E Ratio7.4
ROE15.30%
ROA6.40%
Debt/Equity0.32
P/B Ratio1.1
Op. Cash Flow$99.6M
Free Cash Flow$-6447875
Industry P/E21.6
Technical Analysis
TrendNeutral
RSI49.1
Support$14.37
Resistance$16.09
MA 20$15.26
MA 50$15.57
MA 200$14.17
MACDBullish
VolumeStable
Fear & Greed Index91.36
Valuation
Fair Value$51.89
Target Price$15.00
Upside/Downside-1.70%
GradeUndervalued
TypeBlend
Dividend Yield3.40%
Risk Assessment
Beta-0.25
Volatility40.98%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.